Works matching IS 23638907 AND DT 2024 AND VI 39 AND IP 4


Results: 9
    1

    CYP2C19 genotype-phenotype correlation: current insights and unanswered questions.

    Published in:
    Drug Metabolism & Personalized Therapy, 2024, v. 39, n. 4, p. 201, doi. 10.1515/dmpt-2024-0093
    By:
    • Torso, Nadine de Godoy;
    • Rodrigues-Soares, Fernanda;
    • Altamirano, Catalina;
    • Ramírez-Roa, Ronald;
    • Sosa-Macías, Martha;
    • Galavíz-Hernández, Carlos;
    • Terán, Enrique;
    • Peñas-LLedó, Eva;
    • Dorado, Pedro;
    • LLerena, Adrián
    Publication type:
    Article
    2

    Frontmatter.

    Published in:
    Drug Metabolism & Personalized Therapy, 2024, v. 39, n. 4, p. i, doi. 10.1515/dmpt-2024-frontmatter4
    Publication type:
    Article
    3
    4
    5
    6

    Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.

    Published in:
    Drug Metabolism & Personalized Therapy, 2024, v. 39, n. 4, p. 183, doi. 10.1515/dmpt-2024-0042
    By:
    • Apellaniz-Ruiz, Maria;
    • Barrachina, Jordi;
    • Castro-Sanchez, Paula;
    • Comes-Raga, Ana;
    • García-González, Xandra;
    • Gil-Rodriguez, Almudena;
    • Lopez-Lopez, Elixabet;
    • Maroñas, Olalla;
    • Morón, Rocío;
    • Muriel, Javier;
    • Olivera, Gladys G.;
    • Riera, Pau;
    • Saiz-Rodríguez, Miriam;
    • Salvador-Martín, Sara;
    • Sans-Pola, Carla;
    • Tejera-Pérez, Hugo;
    • Velasco-Ruiz, Alejandro;
    • Verde, Zoraida;
    • Wang, Daniel;
    • Rodríguez-Vicente, Ana E.
    Publication type:
    Article
    7
    8
    9